Health ❯ Clinical Trials

Phase II Trials

Phase III Trials PIVOT-HD Trial Bocunebart Trial Heart Attack Immunotherapy Trials Combination Therapies Weight Loss Drugs

Pacibekitug Cuts hs-CRP by Up to 89% in Phase II Kidney Disease Trial

Durable IL-6 suppression was achieved with infrequent dosing that needs confirmation of clinical benefit in larger phase III trials.

GSK to Acquire Rapt Therapeutics for $2.2 Billion to Add Anti‑IgE Food‑Allergy Drug

PTC Therapeutics and Novartis Sign $3 Billion Deal for Huntington's Disease Drug Development

FDA Grants Breakthrough Status to LSD-Based Anxiety Drug